Experimental Screening of Dihydrofolate Reductase Yields a “Test Set” of 50,000 Small Molecules for a Computational Data-Mining and Docking Competition

Abstract

High-throughput screening (HTS) generates an abundance of data that are a valuable resource to be mined. Dockers and data miners can use “real-world” HTS data to test and further develop their tools. A screen of 50,000 diverse small molecules was carried out against Escherichia coli dihydrofolate reductase (DHFR) and compared with a previous screen of 50,000 compounds against the same target. Identical assays and conditions were maintained for both studies. Prior to the completion of the second screen, the original screening data were publicly released for use as a “training set,” and computational chemists and data analysts were challenged to predict the activity of compounds in this second “test set.” Upon completion, the primary screen of the test set generated no potent inhibitors of DHFR activity.

Keywords

DHFR high-throughput screening data mining chemical space competition

References

Zolli-Juran M , Cechetto JD , Hartlen R , Daigle DM , Brown ED : High throughput screening identifies novel inhibitors ofEscherichia coli dihydrofolate reductase that are competitive with dihydrofolate. Bioorg Med Chem Lett 2003;13:2493-2496.

TaiN , DingY , SchmitzJC , ChuE :Identification of critical amino acid residues on human dihydrofolate reductase protein that mediate RNA recognition.Nucleic Acids Res 2002;30:4481-4488.

Copeland RA : Mechanistic considerations in high-throughput screening. Anal Biochem 2003;320:1-12.

Zhang JH , Chung TD , Oldenburg KR : A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J Biomol Screen 1999;4:67-73.

Bender A , Mussa HY , Glen RC : Screening for dihydrofolate reductase inhibitors using MOLPRINT 2D, a fast fragment-based method employing the naïve Bayesian classifier: limitations of the descriptor and the importance of balanced chemistry in training and test sets. J Biomol Screen 2005;10: 658-666.

Bohacek RS , McMartin C , Guida WC : The art and practice of structure-based drug design: a molecular modeling perspective. Med Res Rev 1996;16:3-50.

Ryan AJ , Gray NM , Lowe PN , Chung CW : Effect of detergent on “promiscuous” inhibitors. J Med Chem 2003;46:3448-3451.

McGovern SL , Caselli E , Grigorieff N , Shoichet BK : A common mechanism underlying promiscuous inhibitors from virtual and high-throughput screening. J Med Chem 2002;45:1712-1722.

Brenk R , Irwin JJ , Shoichet BK : Here be dragons: docking and screening in an uncharted region of chemical space.J Biomol Screen 2005;10:667-674.